Human myeloid-derived suppressor cells (MDSCs) treated with 10 ng/mL Recombinant Human IL‑6 (Catalog # 206-IL) and 10 ng/mL Recombinant Human GM‑CSF (Catalog # 215-GM) for 7 days were stained with Mouse Anti-Human ...read more
12 months from date of receipt, 2 to 8 °C as supplied.
Buffer
Supplied in a saline solution containing BSA and Sodium Azide.
Preservative
Sodium Azide
Purity
Protein A or G purified from hybridoma culture supernatant
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Indoleamine 2,3-dioxygenase/IDO Antibody (700838) [Phycoerythrin]
3dioxygenase
EC 1.13.11.52
IDO
IDO1
IDOIDO-1
INDO
INDOindole 2,3-dioxygenase
Indoleamine 2
indoleamine 2,3-dioxygenase 1
Indoleamine 2,3-dioxygenase
indoleamine-pyrrole 2,3 dioxygenase
Indoleamine-pyrrole 2,3-dioxygenase
Background
Indoleamine 2,3-dioxygenase (also known as IDO) is a heme-containing intracellular dioxygenase catalyzing the degradation of the essential amino acid L-tryptophan to N‑formyl‑kynurenine (1). This degradation is the first and rate-limiting step of the L-kynurenine pathway (2). IDO is widely expressed in dendritic cells, macrophages, microglia, eosinophils, fibroblasts, endothelial cells, and most tumor cells. In immune cells, its expression is mainly induced by cytokines such as IFN-gamma, IFN-alpha, IFN‑ beta, and IL-10. IDO has an antimicrobial function due to its decreasing the availability of the essential amino acid tryptophan in inflammatory environments (3). Recent studies have demonstrated that IDO induces immunosuppression during infection, pregnancy, transplantation, autoimmunity, and neoplasia (3-5).
Lewis-Ballester, A. et al. (2009) Proc. Natl. Acad. Sci. USA. 106:17371.
Costantino, G. (2009) Expert Opin. Ther. Targets 13:247.
Xu, H. et al. (2008) Immunol. Lett. 121:1.
Lob, S. et al. (2009) Nat. Rev. Cancer 9:445.
Curti, A. et al. (2009) Blood 113:2394.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P) (0)
There are no reviews for Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P) (0)
Bioinformatics Tool for Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P)
Discover related pathways, diseases and genes to Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P)
Discover more about diseases related to Indoleamine 2,3-dioxygenase/IDO Antibody (IC6030P).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Indoleamine 2,3-dioxygenase/IDO Antibody (700838) [Phycoerythrin] and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.